AI-supported chronic-disease management platform, including a connected smart glucometer.
Regulatory status
FDA-cleared connected measurement devices, including the smart glucometer.
Clinical evidence
Vendor-supported
Specialized financial press citing a fifth Fortune 50 client added to the platform.
Independent
Not found in this research pass — verify before publishing.
Real-world deployment
B2B2C model: clients are large employers providing the platform to their employees, rather than direct hospital deployment — a different distribution model than most other entries in this batch.
Interoperability
European status
Editorial verdict
Limits and uncertainties
Confirm with Mohammed whether an employer-distributed chronic-care platform fits the site’s hospital-focused scope.
This profile is not medical advice or an endorsement. Hospitals should perform their own due diligence (regulatory compliance, GDPR, cybersecurity, integration, local clinical validation). How we evaluate
Every profile documents the precise indication, regulatory status, vendor-supported and independent evidence, real-world deployment, limits and dated sources.
A independent systematic review or prospective multicentre study · B at least one independent peer-reviewed study · C peer-reviewed, vendor-supported · D vendor claims only.